Colorectal Cancer Metastatic
208
53
69
63
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
22 trials with published results (11%)
Research Maturity
63 completed trials (30% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.6%
20 terminated out of 208 trials
75.9%
-10.6% vs benchmark
10%
20 trials in Phase 3/4
35%
22 of 63 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 63 completed trials
Clinical Trials (208)
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
Assessing How Normal Variations in CT Scanning Affects Its Interpretation
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer
Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers
METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin
Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer
Ablation vs Resection of Colorectal Cancer Liver Metastases
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Evaluation of the Efficacy of Two Guidance Techniques (Standard Injected CT vs Porto-scanner With Angio-CT) for Thermoablation Treatment of Colorectal Cancer Liver Metastases
A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer